Form 8-K - Current report:
SEC Accession No. 0001104659-21-011530
Filing Date
2021-02-03
Accepted
2021-02-03 16:10:52
Documents
2
Period of Report
2021-01-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm214882d1_8k.htm 8-K 25614
2 EXHIBIT 10.1 tm214882d1_ex10-1.htm EX-10.1 10920
  Complete submission text file 0001104659-21-011530.txt   37761
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 21586305
SIC: 2834 Pharmaceutical Preparations